Conferencia 'Nanotechnology in medicine: From its foundation to now saving human lives'
Fecha evento
El investigador de la Universidad de Province (EEUU) Thomas J. Webster ofrece la conferencia 'Nanotechnology in medicine: From its foundation to now saving human lives' el 5 de febrero a las 12.30 horas en el salón de grados de la Facultad de Farmacia de la Universidad de Sevilla.
This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment which has led to numerous products including nano spinal implants now in over 30,000 patients to date showing no signs of failure according to the FDA MAUDE database. Traditional orthopedic implants face a failure rate of 5 – 10% and sometimes as high as 60% for bone cancer patients. The talk will cover not only human clinical evidence of the unprecedented efficacy of nanotechnology in medicine but also fundamental evidence of how nanotechnology can be used clinically to kill bacteria, inhibit inflammation, and promote tissue growth (if needed) without drugs. This talk will also describe the future of nanotechnology and how it will in the not too distant future combat traditional failures in our global healthcare system including reversing the current decrease in global average life expectancy, creating a reactive compared to predictive healthcare system, transforming a healthcare system that relies too much on drugs and pharmaceutical agents to treat ailments, facilitating a non-personalized healthcare system, combating increasing costs, treating a growing global population, and more through the future use of implantable nano sensors, 4D printed nano materials, smart nano materials, environmentally-friendly nanomaterials, and AI as well as other predictive models in medicine and more.
Bio: Thomas J. Webster’s (H index: 129; Google Scholar) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has served as a professor at Purdue (2000-2005), Brown (2005-2012; 2021-present), and Northeastern (2012-2021; serving as Chemical Engineering Department Chair from 2012 - 2019) Universities and has formed over a dozen companies (with some acquired by Medtronic) who have numerous FDA approved medical products currently improving human health in over 30,000 patients with no failures. He is currently helping those companies and serves as a professor at Brown University, Saveetha University, Hebei University of Technology, UFPI, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies. Prof. Webster is a former President of the U.S. Society for Biomaterials and has over 1,350 publications to his credit with over 70,000 citations. He was recently nominated for the Nobel Prize in Chemistry. Prof. Webster also recently formed a fund to support Nigerian student research opportunities in the U.S.